Goens M, Howard E, Warner B, Susta L, Wootton S
Viruses. 2024; 16(11).
PMID: 39599908
PMC: 11599079.
DOI: 10.3390/v16111794.
Yudaeva A, Kostyusheva A, Kachanov A, Brezgin S, Ponomareva N, Parodi A
Cells. 2024; 13(22).
PMID: 39594663
PMC: 11592828.
DOI: 10.3390/cells13221916.
Jogi H, Smaraki N, Rajak K, Yadav A, Bhatt M, Einstien C
Indian J Microbiol. 2024; 64(3):867-878.
PMID: 39282171
PMC: 11399537.
DOI: 10.1007/s12088-024-01341-3.
Yan S, Luo Y, Zhan N, Xu H, Yao Y, Liu X
Microbiol Spectr. 2024; 12(10):e0069224.
PMID: 39145626
PMC: 11448059.
DOI: 10.1128/spectrum.00692-24.
Fischer J, Fedotova A, Buhler C, Darriba L, Schreiner S, Ruzsics Z
Viruses. 2024; 16(5).
PMID: 38793540
PMC: 11125593.
DOI: 10.3390/v16050658.
Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries.
Fischer J, Fedotova A, Jaki L, Sallard E, Erhardt A, Fuchs J
Mol Ther Methods Clin Dev. 2024; 32(2):101241.
PMID: 38585687
PMC: 10995876.
DOI: 10.1016/j.omtm.2024.101241.
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner.
Zeng M, Zhang W, Li Y, Yu L
Biomark Res. 2024; 12(1):36.
PMID: 38528632
PMC: 10962185.
DOI: 10.1186/s40364-024-00581-1.
Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines.
Trivedi P, Byrne B, Corti M
Viruses. 2023; 15(12).
PMID: 38140619
PMC: 10747483.
DOI: 10.3390/v15122378.
A Method to Generate and Rescue Recombinant Adenovirus Devoid of Replication-Competent Particles in Animal-Origin-Free Culture Medium.
Elahi S, Jiang J, Nazemi-Moghaddam N, Gilbert R
Viruses. 2023; 15(11).
PMID: 38005830
PMC: 10674172.
DOI: 10.3390/v15112152.
Gene therapy during heart perfusion: a new frontier in cardiac regenerative medicine?.
Vervoorn M, Amelink J, Ballan E, Doevendans P, Sluijter J, Mishra M
Front Cardiovasc Med. 2023; 10:1264449.
PMID: 37908499
PMC: 10614057.
DOI: 10.3389/fcvm.2023.1264449.
Construction and application of adenoviral vectors.
Zhang H, Wang H, An Y, Chen Z
Mol Ther Nucleic Acids. 2023; 34:102027.
PMID: 37808925
PMC: 10556817.
DOI: 10.1016/j.omtn.2023.09.004.
Targeted DNA Demethylation: Vectors, Effectors and Perspectives.
Yano N, Fedulov A
Biomedicines. 2023; 11(5).
PMID: 37239005
PMC: 10215725.
DOI: 10.3390/biomedicines11051334.
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy.
Ahmadi S, Soleymani M, Shahriyary F, Amirzargar M, Ofoghi M, Fattahi M
Cancer Gene Ther. 2023; 30(7):936-954.
PMID: 36854897
PMC: 9971689.
DOI: 10.1038/s41417-023-00597-z.
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.
Chavda V, Bezbaruah R, Valu D, Patel B, Kumar A, Prasad S
Vaccines (Basel). 2023; 11(2).
PMID: 36851309
PMC: 9965371.
DOI: 10.3390/vaccines11020432.
Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses.
Shoushtari M, Roohvand F, Salehi-Vaziri M, Arashkia A, Bakhshi H, Azadmanesh K
Hum Vaccin Immunother. 2022; 18(5):2079323.
PMID: 35714271
PMC: 9481145.
DOI: 10.1080/21645515.2022.2079323.
Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.
Jt S, M H, Wam B, Ac B, Sa N
J Mol Med (Berl). 2022; 100(6):875-901.
PMID: 35606652
PMC: 9126699.
DOI: 10.1007/s00109-022-02208-0.
Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells.
Nilson R, Lubbers O, Schmidt C, Rojewski M, Zeplin P, Funk W
Mol Ther Methods Clin Dev. 2022; 25:96-110.
PMID: 35402633
PMC: 8956844.
DOI: 10.1016/j.omtm.2022.03.004.
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.
Su W, Patricio M, Duffy M, Krakowiak J, Seymour L, Cawood R
Nat Commun. 2022; 13(1):1182.
PMID: 35256603
PMC: 8901928.
DOI: 10.1038/s41467-022-28738-2.
E4orf1 Suppresses -Deleted Adenovirus Vaccine-Induced Immune Responses.
Sangare K, Hait S, Moore M, Hogge C, Hoang T, Rahman M
Vaccines (Basel). 2022; 10(2).
PMID: 35214753
PMC: 8875587.
DOI: 10.3390/vaccines10020295.
Recombinant adenovirus causes prolonged mobilization of macrophages in the anterior chambers of mice.
Meyer K, Pellack D, Hedberg-Buenz A, Pomernackas N, Soukup D, Wang K
Mol Vis. 2022; 27:741-756.
PMID: 35136346
PMC: 8763664.